Alto Healthcare Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 06-07-2024
- Paid Up Capital ₹ 1.87 M
as on 06-07-2024
- Company Age 21 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.09 Cr
as on 06-07-2024
- Revenue -25.78%
(FY 2022)
- Profit -756.69%
(FY 2022)
- Ebitda 3102.43%
(FY 2022)
- Net Worth -22.55%
(FY 2022)
- Total Assets -50.59%
(FY 2022)
About Alto Healthcare
The Corporate was formerly known as Kanodia Impex Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.87 M.
The company currently has active open charges totaling ₹2.09 Cr.
Suchita Kumari, Sudhira Jha, and Mihir Jha serve as directors at the Company.
- CIN/LLPIN
U51909DL2003PTC122976
- Company No.
122976
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Nov 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Alto Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suchita Kumari  | Director | 22-Jan-2016 | Current |
| Sudhira Jha | Director | 15-Mar-2021 | Current |
| Mihir Jha | Director | 15-Mar-2021 | Current |
Financial Performance of Alto Healthcare.
Alto Healthcare Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 25.78% decrease. The company also saw a substantial fall in profitability, with a 756.69% decrease in profit. The company's net worth observed a substantial decline by a decrease of 22.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alto Healthcare?
In 2021, Alto Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Man Care Laboratories Private LimitedActive 18 years 4 months
Sudhira Jha and Mihir Jha are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 20 Jan 2015 | ₹2.00 Cr | Open |
Canara Bank Creation Date: 22 Feb 2013 | ₹0.45 M | Open |
Canara Bank Creation Date: 19 Feb 2013 | ₹0.45 M | Open |
How Many Employees Work at Alto Healthcare?
Alto Healthcare has a workforce of 5 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alto Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alto Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
